Statistical characteristics of moxifloxacin-induced QTc effect.
about
Drug-induced QT interval prolongation: does ethnicity of the thorough QT study population matter?Early QT assessment--how can our confidence in the data be improved?The effects of moxifloxacin on QTc interval in healthy Korean male subjectsThorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjectsA thorough QT study in the context of an uptitration regimen with selexipag, a selective oral prostacyclin receptor agonistNo effect of a single supratherapeutic dose of lersivirine, a next-generation nonnucleoside reverse transcriptase inhibitor, on corrected QT interval in healthy subjectsMoxifloxacin-induced QTc interval prolongations in healthy male Japanese and Caucasian volunteers: a direct comparison in a thorough QT study.Update on the cardiac safety of moxifloxacin.ICH E14 Q & A (R1) document: perspectives on the updated recommendations on thorough QT studies.Evaluation of the effect of a supratherapeutic dose of intravenous ceftaroline fosamil on the corrected QT interval.Effect of Cabotegravir on Cardiac Repolarization in Healthy Subjects.A randomized, double-blind, placebo-controlled study to evaluate the effect of repeated oral doses of pazopanib on cardiac conduction in patients with solid tumors.Moxifloxacin Increases Heart Rate in Humans.Early investigation of QTc liability: the role of multiple ascending dose (MAD) study.Dealing with global safety issues : was the response to QT-liability of non-cardiac drugs well coordinated?Population pharmacokinetics of moxifloxacin and its concentration-QT interval relationship modeling in Chinese healthy volunteers.Detection of QT prolongation using a novel electrocardiographic analysis algorithm applying intelligent automation: prospective blinded evaluation using the Cardiac Safety Research Consortium electrocardiographic database.Replacing the thorough QT study: reflections of a baby in the bath water.Multiple comparisons of repeatedly measured response: issues of validation testing in thorough QT/QTc clinical trials.Bayesian approach to assay sensitivity analysis of thorough QT trials.Sample size of thorough QTc clinical trial adjusted for multiple comparisons.Effect of nalmefene 20 and 80 mg on the corrected QT interval and T-wave morphology: a randomized, double-blind, parallel-group, placebo- and moxifloxacin-controlled, single-centre study.
P2860
Q27006580-B08F985C-D46A-40C4-99B3-3AE97594AE14Q27020964-C2B1C502-5754-4DDD-8476-E759AED9D3B6Q33804792-63626EBD-E190-4CD1-B74A-FE3FCAB7C988Q34347165-30CADBEE-0627-49A6-B439-ACE5C3B46099Q34775420-FAAD5767-C0DB-4BE5-BA47-D9AA074CF3E0Q35941313-538F973C-8F5C-4822-BD57-F21899D4E938Q36072475-30ED706E-7BD6-4DE5-A5ED-1A6B0F55D7F7Q36345861-4CE3AEE1-5457-427C-BA81-01BFFC3CFB77Q36729914-FB8BA084-F18C-4B6F-83C0-A1597D999D5AQ36757657-74D89BBE-36B5-4974-9113-C3AF7B8F66C3Q37462061-BEEAC845-023D-471E-8F5D-5585B8CF0A41Q37507871-7238E746-1666-4C81-BE09-2D87B92B787EQ37729919-EDDC81F7-2A1C-4127-8DB2-77F1A3A6F406Q38030582-9377015E-681D-4205-B32F-52E08D84C1FEQ38082420-3C932601-34E2-4D45-8D26-47CBB02B0F91Q38676631-ED354C71-72DA-4B11-9C18-8C7B75F9598CQ40026484-9D658799-B85B-47DB-B005-7B0334EFDCB0Q42069989-97B413CB-849E-4770-9293-FBD25A14D4F3Q45729459-26064369-539E-406C-A54F-4EE9304D0577Q45742817-3216911E-DAAB-487C-99C0-436BE7E3B66BQ47259988-FB82753D-2128-4DCF-A761-0D5A7CD11BE8Q51406750-70BE6829-F4C8-4372-9385-66498BE70FD2
P2860
Statistical characteristics of moxifloxacin-induced QTc effect.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Statistical characteristics of moxifloxacin-induced QTc effect.
@en
Statistical characteristics of moxifloxacin-induced QTc effect.
@nl
type
label
Statistical characteristics of moxifloxacin-induced QTc effect.
@en
Statistical characteristics of moxifloxacin-induced QTc effect.
@nl
prefLabel
Statistical characteristics of moxifloxacin-induced QTc effect.
@en
Statistical characteristics of moxifloxacin-induced QTc effect.
@nl
P2093
P2860
P1476
Statistical characteristics of moxifloxacin-induced QTc effect.
@en
P2093
Joanne Zhang
Lihan K Yan
Moh Jee Ng
Qianyu Dang
P2860
P304
P356
10.1080/10543400903581945
P577
2010-05-01T00:00:00Z